Reader T A, Brière R, Grondin L
Neurochem Res. 1986 Jan;11(1):9-27. doi: 10.1007/BF00965161.
The tritiated adrenergic antagonists Prazosin ([3H]PRZ) and Idazoxan ([3H]IDA, or RX-781094) bind specifically and with high affinity to alpha 1 and alpha 2-adrenoceptors respectively, in membrane preparations from cerebral cortex. Saturation experiments performed to determine the density of receptors and the dissociation constant (Kd) were analyzed by the methods of Eadie Hofstee, iterative modelling, and the procedure of Hill, while the specificity of the labelling was verified by displacement experiments. Since receptors are proteins, we examined the role of disulfide (-SS-) bridges and sulfhydryl (-SH) groups in the specific combination of [3H]PRZ and [3H]IDA to the alpha 1 and alpha 2 adrenoceptors. Pretreatment of the membranes with the -SS- reactive DL-dithiothreitol (DTT) or the alkylating agent N-ethylmaleimide (NEM), alone or in combination, decreased specific binding of both ligands, with only minor changes in the non-specific counts. The [3H]IDA binding (alpha 2-sites) was more sensitive to both DTT and NEM than the [3H]PRZ sites (alpha 1-adrenoceptors), and the initial changes induced by alkylation of the alpha 2-site were due to an important decrease in the affinity for [3H]IDA, as judged by the increase in the Kd. This modulation in the affinity caused by alkylation of a thiol group could explain the higher potency of the blocking agent tetramine disulfide benextramine at the alpha 2-site. The results provide evidence for the participation of -SS- and -SH groups in the binding site of alpha 1- and alpha 2-adrenoceptors in the cerebral cortex.
氚标记的肾上腺素能拮抗剂哌唑嗪([3H]PRZ)和咪唑克生([3H]IDA,或RX - 781094)分别与大脑皮质膜制剂中的α1和α2肾上腺素能受体特异性且高亲和力地结合。通过伊迪 - 霍夫斯蒂方法、迭代建模和希尔程序分析用于确定受体密度和解离常数(Kd)的饱和实验,同时通过置换实验验证标记的特异性。由于受体是蛋白质,我们研究了二硫键(-SS-)和巯基(-SH)基团在[3H]PRZ和[3H]IDA与α1和α2肾上腺素能受体特异性结合中的作用。用-SS-反应性二硫苏糖醇(DTT)或烷基化剂N - 乙基马来酰亚胺(NEM)单独或联合预处理膜,会降低两种配体的特异性结合,而非特异性计数仅有微小变化。[3H]IDA结合(α2位点)对DTT和NEM的敏感性均高于[3H]PRZ位点(α1肾上腺素能受体),α2位点烷基化引起的初始变化是由于对[3H]IDA的亲和力显著降低,这可通过Kd的增加来判断。由硫醇基团烷基化引起的这种亲和力调节可以解释阻断剂四胺二硫苯苄胺在α2位点的更高效力。结果为-SS-和-SH基团参与大脑皮质中α1和α2肾上腺素能受体的结合位点提供了证据。